Update on the rights issue following the receipt of a non-binding
offer from the French State to acquire the Advanced Computing
activities
NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY,
IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN.
THIS PRESS RELEASE IS AN ADVERTISEMENT AND NOT A PROSPECTUS
WITHIN THE MEANING OF REGULATION (EU) 2017/1129 OF THE EUROPEAN
PARLIAMENT AND OF THE COUNCIL OF JUNE 14, 2017
Press Release
Update on the rights issue following the
receipt of a non-binding offer from the French State to acquire the
Advanced Computing activities
Paris, France – November 25, 2024
– Following the receipt of a non-binding offer from the
French State regarding the acquisition of Advanced Computing
business1, Atos SE (Euronext Paris: ATO) (the
"Company" or "Atos") announces
today the approval by the French Autorité des marchés
financiers (the “AMF”) of the supplement
under number 24-501 dated 25 November 2024 (the
“Supplement”) which supplements and should be read
in conjunction with the prospectus approved by the AMF on 7
November 2024, under number 24-474 (the
“Prospectus”) in connection with the rights issue
of a gross amount of EUR 233,332,768.4985, including issue premium
launched on 8 November 2024 (the “Rights
Issue”).
Impact on the Timetable: Extension of
the Subscription Period and Right of Withdrawal
Pursuant to Article 23 of the Prospectus
Regulation (EU) 2017/1129, investors who have already agreed to
subscribe to new shares (the “New Shares”) prior
to the publication of the Supplement shall have the right to
withdraw their acceptance within two working days after the
publication of the Supplement. As a result, the withdrawal period
will be open on 26 and 27 November 2024. Investors who wish to
exercise their right of withdrawal must contact their financial
intermediary with whom they have placed their subscription order
for intermediary registered or bearer shareholders and Societe
Generale Securities Services for direct registered
shareholders.
This withdrawal period will result in the
postponement of the end of the subscription period to 27 November
2024 (initially scheduled for 25 November 2024).
The changes to the timetable are set out in the
Supplement and the new indicative timetable is as follows:
Updated indicative timetable for the Rights
Issue |
25 November 2024 |
Approval of the Supplement by the AMF
Issuance of a press release by the Company announcing the approval
of the Supplement and describing the investors’ right of
withdrawal, as well as the procedures for making the Supplement
available
Publication of the Supplement and posting on the Company and AMF
websites
Publication by Euronext of the notice relating to the approval of a
Supplement announcing the updated timetable. |
From 26 to 27 November 2024 |
Right to withdraw their acceptance for the investors who have
already agreed to subscribe for New Shares prior to the publication
of this Supplement |
27 November 2024 |
Closing of the subscription period for the Rights Issue |
2 December 2024 |
Issuance by the Company of a press release announcing the result of
subscriptions to the Rights Issue.
Decision by the Company’s Chief Executive Officer to (i) allocate
the New Shares not subscribed for in the Rights Issue, to be
subscribed for by the Participating Bondholders and the
Participating Creditors under the Subscription Guarantee
Commitments and (ii) record the completion of the Share Capital
Reduction provided for in the Accelerated Safeguard Plan.
Publication by Euronext of the notice of admission of the New
Shares resulting from the Rights Issue and indicating the
allocation scale for subscriptions on a reducible basis (à
titre réductible). |
10 December 2024 |
Settlement-delivery of the New Shares in respect of the Rights
Issue
Admission of the New Shares to trading on Euronext Paris |
The public will be informed of any changes to the above
indicative timetable by means of a press release issued by the
Company and posted on its website, and a notice
issued by Euronext. |
Settlement and Delivery
According to the indicative timetable the
settlement-delivery of the New Shares and their admission to
trading on Euronext Paris are expected to take place on 10 December
2024.The New Shares will carry all rights attached from the date of
issue and will be entitled to all distributions decided by the
Company from that date. They will be immediately assimilated with
existing shares of the Company already traded on Euronext Paris and
will be tradable, as from this date, on the same trading line under
the same ISIN code FR0000051732.
Barclays Bank Ireland PLC is acting as Global
Coordinator and Joint Bookrunner (the “Global Coordinator
and Joint Bookrunner”) and Deutsche Bank AG and ING Bank
N.V. are acting as Joint Bookrunners (“Joint
Bookrunners”) in respect of the Rights Issue.
Rothschild & Co and Perella Weinberg
Partners act as financial advisors to the Company, Darrois Villey
Maillot Brochier as legal advisor to the Company and Linklaters as
legal advisor to the Global Coordinator and the Joint
Bookrunners.
Availability of the Prospectus
The Prospectus approved by the AMF under number
24-474 on 7 November 2024, consisting of (i) Atos’ 2023 universal
registration document filed with the AMF on May 24, 2024 under
number D.24-0429, (ii) the amendment to the 2023 universal
registration document filed with the AMF on 7 November 2024 under
number D.24-0429-A01 (the “Amendment”) and (iii) a
securities note (including the summary of the Prospectus) dated
November 7, 2024 (the “Securities Note”) and that
the Supplement to the Prospectus approved by the AMF under number
24-501 dated 25 November 2024 are available on the websites of Atos
(www.atos.net) as well as on the website of the AMF
(www.amf-france.org). Copies of the Prospectus and the Supplement
are available free of charge at Atos' registered office (River
Ouest – 80 Quai Voltaire – 95870 Bezons).
Risk Factors
Investors’ attention is drawn to the risk
relating to Atos described in paragraph 7.2 “Risk Factors”
of the 2023 Atos Universal Registration Document, as updated by
Chapter 2 “Risk Factors” of the Amendment and Chapter 1.2
of the Supplement, the risk factors relating to the Rights Issue or
the New Shares mentioned in section 2 “Risk Factors” of
the Securities Note, as updated by Chapter 3.1 of the Supplement,
before making any investment decision.
***
Disclaimer
This document must not be published, released or
distributed, directly or indirectly, in the United States, Canada,
Japan or Australia.
This press release and the information contained
herein do not constitute an offer to sell nor a solicitation of an
offer to buy, nor shall there be any sale of ordinary shares in any
State or jurisdiction in which such an offer, solicitation or sale
would be unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
The distribution of this press release may, in
certain jurisdictions, be restricted by local legislations. Persons
into whose possession this press release comes are required to
inform themselves about and to observe any such potential local
restrictions.
This press release is an advertisement and not a
prospectus within the meaning of Regulation (EU) 2017/1129 of the
European Parliament and of the Council of 14 June 2017, as amended
(the “Prospectus Regulation”). Potential investors are advised to
read the Prospectus before making an investment decision in order
to fully understand the potential risks and rewards associated with
the decision to invest in the securities. The approval of the
prospectus by the AMF should not be understood as an endorsement of
the securities offered or admitted to trading on a regulated
market.
With respect to each Member State of the
European Economic Area (other than France) and the United Kingdom
(a “Relevant State”), no action has been undertaken or will be
undertaken to make an offer to the public of securities requiring
the publication of a prospectus in any Relevant State. As a result,
the securities may and will be offered in any Relevant State only
(i) to qualified investors within the meaning of the Prospectus
Regulation, for any investor in a Member State of the European
Economic Area, or Regulation (EU) 2017/1129 as part of national law
under the European Union (Withdrawal) Act 2018 (the “UK Prospectus
Regulation”), for any investor in the United Kingdom, (ii) to fewer
than 150 individuals or legal entities (other than qualified
investors as defined in the Prospectus Regulation or the UK
Prospectus Regulation, as the case may be), or (iii) in accordance
with the exemptions set forth in Article 1 (4) of the Prospectus
Regulation or under any other circumstances which do not require
the publication by Atos of a prospectus pursuant to Article 3 of
the Prospectus Regulation, of the UK Prospectus Regulation and/or
to applicable regulations of that Relevant State.
The distribution of this press release has not
been made, and has not been approved, by an “authorised person”
within the meaning of Article 21(1) of the Financial Services and
Markets Act 2000. As a consequence, this press release is only
being distributed to, and is only directed at, persons in the
United Kingdom that (i) are “investment professionals” falling
within Article 19(5) of the Financial Services and Markets Act 2000
(Financial Promotion) Order 2005 (as amended, the “Order”), (ii)
are persons falling within Article 49(2)(a) to (d) (“high net worth
companies, unincorporated associations, etc.”) of the Order, or
(iii) are persons to whom an invitation or inducement to engage in
investment activity (within the meaning of Article 21 of the
Financial Services and Markets Act 2000) in connection with the
issue or sale of any securities may otherwise lawfully be
communicated or caused to be communicated (all such persons
together being referred to as “Relevant Persons”). Any investment
or investment activity to which this press release relates is
available only to Relevant Persons and will be engaged in only with
Relevant Persons. Any person who is not a Relevant Person should
not act or rely on this press release or any of its contents.
This press release is not an offer of securities
for sale nor the solicitation of an offer to purchase securities in
the United States or any other jurisdiction in which such offer or
solicitation is not authorised or to any person to whom it is
unlawful to make such offer or solicitation. The securities
referred to herein have not been and will not be registered under
the US Securities Act of 1933, as amended (the “Securities Act”)
and may not be offered or sold in the United States absent
registration under or pursuant to an exemption from, or in a
transaction not subject to, the registration requirements of the
Securities Act. Atos does not intend to register any portion of the
planned offer in the United States or to conduct a public offering
of securities in the United States.
Forward-looking information
This press release contains “forward-looking
statements”, including statements regarding the future prospects
and development of the Atos Group. All statements other than
statements of historical data included in this press release,
including, without limitation, statements regarding Atos' financial
condition, business strategy, plans and objectives of management
for future operations, are forward-looking statements. These
forward-looking statements can be identified by the use of the
future or conditional tense, or forward-looking terminology such as
“consider”, “envisage”, “think”, “aim”, “expect”, “intend”,
“should”, “aim”, “estimate”, “believe”, “wish”, “may” or, where
appropriate, the negative of these terms, or any other similar
variants or expressions. This information is not historical data
and should not be construed as a guarantee that the facts and data
stated will occur. These forward-looking statements are based on
data, assumptions and estimates considered reasonable by Atos.
These forward-looking statements are based on data, assumptions and
estimates considered reasonable by Atos. They may change or be
modified as a result of uncertainties linked in particular to the
economic, financial, competitive and regulatory environment. In
addition, the materialization of certain risks described in section
7.2 “Risk factors” of Atos' 2023 universal registration document,
as updated by chapter 2 “Risk factors” of the amendment to Atos'
2023 universal registration document and in section 2 “Risk
factors” of the securities note, is likely to have a material
adverse effect on Atos' business, financial condition and results
and its ability to achieve its objectives. All forward-looking
statements included in this press release speak only as of the date
of this press release. Except as required by applicable law or
regulation, Atos undertakes no obligation to publicly update any
forward-looking statement contained in this press release to
reflect any change in Atos' objectives or in the events, conditions
or circumstances on which any forward-looking statement is based,
and disclaims any intention or obligation to update any
forward-looking statement, whether as a result of new information,
future events or otherwise. Atos' past performance should not be
taken as a guide to future performance.
About
Atos
Atos is a global
leader in digital transformation with circa 82,000 employees and
annual revenue of circa €10 billion. European number one in
cybersecurity, cloud and high-performance computing, the Group
provides tailored end-to-end solutions for all industries in 69
countries. A pioneer in decarbonization services and products, Atos
is committed to a secure and decarbonized digital for its clients.
Atos is a SE (Societas Europaea) and listed on Euronext
Paris.
The purpose of
Atos is to help design the future of the information space.
Its expertise and services support the development of knowledge,
education and research in a multicultural approach and contribute
to the development of scientific and technological excellence.
Across the world, the Group enables its customers and employees,
and members of societies at large to live, work and develop
sustainably, in a safe and secure information space.
Contacts
Investor
relations:
David Pierre-Kahn | investors@atos.net | +33 6 28 51 45 96
Sofiane El Amri | investors@atos.net | +33 6 29 34 85 67
Individual
shareholders: 0805 65 00 75
Press contact: globalprteam@atos.net
1 See the press release published by the Company on 25 November
2024.
- PR- Atos announces publication of a Supplement to
Prospectus
Atos (EU:ATO)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Atos (EU:ATO)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024